CODX Earnings

Quarterly EPS
$-9.60
Q3 2024
$-10.72
Q4 2024
$-7.05
Q1 2025
$-7.00
Q2 2025
$-4.80
Q3 2025
$0.00
Q4 2025
$-4.06
Q1 2026
$-1.46
Q2 2026
Latest Revenue166.1K
Latest Net Income-6283786
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.46166.1K-6283786+2.0%+79.1%
Q1 2026-$4.06146.0K-9140038+190.3%+42.4%
Q4 2025263.9K-25745725+76.7%
Q3 2025-$4.80145.4K-5886823-77.3%+50.0%
Q2 2025-$7.00162.9K-7730117-93.9%+6.7%
Q1 2025-$7.0550.3K-7533271-89.3%+24.2%
Q4 2024-$10.72149.3K-11031192-95.8%+28.3%
Q3 2024-$9.60641.1K-9696455-73.9%-60.0%
Q2 2024-$7.502.7M-7599318
Q1 2024-$9.30467.9K-9312043
Q4 2023-$14.953.6M-14676455
Q3 2023-$6.002.5M-5982194
Co-Diagnostics (CODX) — Earnings